Cart
sales@molnova.com
Lyciumin B
CAS No. 125756-66-3
Lyciumin B( ——— )
Catalog No. M38705 CAS No. 125756-66-3
Lyciumin B is a cyclic peptide isolated from Lysium chinense.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1408 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLyciumin B
-
NoteResearch use only, not for human use.
-
Brief DescriptionLyciumin B is a cyclic peptide isolated from Lysium chinense.
-
DescriptionLyciumin B is a cyclic peptide isolated from Lysium chinense.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number125756-66-3
-
Formula Weight896.959
-
Molecular FormulaC44H52N10O11
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yahara S, et al. Cyclic peptides, acyclic diterpene glycosides and other compounds from Lycium chinense Mill. Chem Pharm Bull (Tokyo). 1993;41(4):703-709.?
molnova catalog
related products
-
Leptin (22-56), huma...
Leptin(22-56),human is a peptide fragment of Leptin, which ACTS through a variety of subtypes of Ob-Rs.
-
Lufotrelvir
Lufotrelvir (PF-07304814) is a small molecule inhibitor of the SARS CoV-2 3CL protease for the treatment of COVID-19 with broad-spectrum anti-SARS activity for the study of novel coronavirus infections.
-
Rhodiocyanoside A
Rhodiocyanoside A has antiallergic activity, it exhibits inhibitory activity on the histamine release from rat peritoneal exudate cells sensitized with anti-DNP IgE and inhibits the PCA reaction in rats.
